ASCEND Therapeutics: Clinical Trials

5 trials sponsored by ASCEND Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 2, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 2
Phase 41Completed 1

Follow ASCEND Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
Paclitaxel Poliglumex - Advanced Colorectal Cancer
Phase 1CompletedUniversity of Southern California152008-01-012014-02-06
Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]
Dihydrotestosterone (DHT) gel (0.7%), Placebo gel - Healthy
Phase 1 / Phase 2CompletedUniversity of Washington312007-06-012011-06-27
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
Estrogel, Placebo - Postmenopausal Symptoms
Phase 4CompletedASCEND Therapeutics2212004-12-022022-09-13
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
Dihydrotestosterone (0.7%) in hydroalcoholic gel - Hypogonadism, Late Onset Hypogonadism
Phase 2CompletedASCEND Therapeutics1282004-10-012022-08-15
Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
Afimoxifene (0.057%) in hydroalcoholic gel - Cyclic Breast Pain, Cyclic Mastalgia
Phase 2CompletedASCEND Therapeutics1462003-03-012023-08-16

Conditions studied

Hypogonadism (1)  ·  Mastodynia (1)

Interventions

Dihydrotestosterone (2)  ·  Estradiol (1)  ·  Gels (1)  ·  afimoxifene (1)  ·  paclitaxel poliglumex (1)

Countries

United States (4)

Top investigators

Neta R Nelson (1)  ·  Robert E Mansel, MD (1)  ·  Stephanie T Page, MD, PhD (1)  ·  Syma Iqbal, M.D. (1)

Results publications

PMID 21177791

NIH funding

K23AG027238 (1)